Plain-English translation of NCT04625023 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
Read our Breast Cancer research guide →METAMECH is a large research study that follows breast cancer patients over several years, collecting tissue samples and detailed medical information at different points in their care. By studying how tumors evolve and interact with the body, researchers hope to identify new ways to predict which patients are at higher risk of cancer returning, and to discover new treatment targets that could improve survival and reduce recurrence.
Most current breast cancer treatments are based on general patterns, but tumors behave differently in different patients. This study exists to understand the biological mechanisms that drive tumor growth and spread, so that doctors can eventually offer more personalized treatments and better predict patient outcomes.
You likely qualify if…
You likely don't qualify if…
You would join the study either before surgery or a biopsy, or before starting a new treatment. Researchers would collect tissue samples during your normal medical procedures and gather information about your cancer and health over time. You would be followed for at least 5 years, during which researchers periodically review your medical records and may ask you to provide updates on your health status. No experimental drugs or invasive procedures would be required beyond what you're already receiving as standard care.
AI-generated summary from trial data · Jun 24, 2026 · Not medical advice
Italy